4//SEC Filing
Burek Julie 4
Accession 0001104659-22-004515
CIK 0001640266other
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 6:14 PM ET
Size
9.0 KB
Accession
0001104659-22-004515
Insider Transaction Report
Form 4
Burek Julie
VP, Finance
Transactions
- Sale
Common Stock
2022-01-03$2.83/sh−3,063$8,668→ 46,522 total - Award
Common Stock
2021-12-31$2.30/sh+3,063$7,045→ 49,585 total - Sale
Common Stock
2022-01-12$3.06/sh−265$811→ 46,257 total
Footnotes (3)
- [F1]Represents shares acquired under the Voyager Therapeutics, Inc. 2015 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(c) and Rule 16b-3(d).
- [F2]Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on January 11, 2022. The reporting person structured the durable automatic sales instructions to constitute a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1. The sales do not represent a discretionary trade by the reporting person.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.92 to $3.22, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
Documents
Issuer
Voyager Therapeutics, Inc.
CIK 0001640266
Entity typeother
Related Parties
1- filerCIK 0001894915
Filing Metadata
- Form type
- 4
- Filed
- Jan 13, 7:00 PM ET
- Accepted
- Jan 14, 6:14 PM ET
- Size
- 9.0 KB